Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-02 | 2022-02-28 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.77 | -48.4K | 586.3K | -8% | -$521.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-28 | S | D | 19,970 | $10.77 | 602,806 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-28 | S | D | 10,026 | $10.77 | 622,776 | D | — | — | |
| 3 | Common | Class A Common Stock | 2022-02-28 | S | D | 1,942 | $10.77 | 632,802 | D | — | — | |
| 4 | Common | Class A Common Stock | 2022-02-28 | S | D | 16,486 | $10.77 | 586,320 | D | — | — |